NEAT1-mediated regulation of proteostasis and mRNA localization impacts autophagy dysregulation in Rett syndrome
- PMID: 39921568
- PMCID: PMC11806351
- DOI: 10.1093/nar/gkaf074
NEAT1-mediated regulation of proteostasis and mRNA localization impacts autophagy dysregulation in Rett syndrome
Abstract
Rett syndrome (RTT) is a severe neurodevelopmental disorder primarily caused by loss-of-function mutations in the MECP2 gene, resulting in diverse cellular dysfunctions. Here, we investigated the role of the long noncoding RNA (lncRNA) NEAT1 in the context of MeCP2 deficiency using human neural cells and RTT patient samples. Through single-cell RNA sequencing and molecular analyses, we found that NEAT1 is markedly downregulated in MECP2 knockout (KO) cells at various stages of neural differentiation. NEAT1 downregulation correlated with aberrant activation of the mTOR pathway, abnormal protein metabolism, and dysregulated autophagy, contributing to the accumulation of protein aggregates and impaired mitochondrial function. Reactivation of NEAT1 in MECP2-KO cells rescued these phenotypes, indicating its critical role downstream of MECP2. Furthermore, direct RNA-RNA interaction was revealed as the key process for NEAT1 influence on autophagy genes, leading to altered subcellular localization of specific autophagy-related messenger RNAs and impaired biogenesis of autophagic complexes. Importantly, NEAT1 restoration rescued the morphological defects observed in MECP2-KO neurons, highlighting its crucial role in neuronal maturation. Overall, our findings elucidate lncRNA NEAT1 as a key mediator of MeCP2 function, regulating essential pathways involved in protein metabolism, autophagy, and neuronal morphology.
© The Author(s) 2025. Published by Oxford University Press on behalf of Nucleic Acids Research.
Conflict of interest statement
The authors declare no competing interests.
Figures









Similar articles
-
Graded and pan-neural disease phenotypes of Rett Syndrome linked with dosage of functional MeCP2.Protein Cell. 2021 Aug;12(8):639-652. doi: 10.1007/s13238-020-00773-z. Epub 2020 Aug 27. Protein Cell. 2021. PMID: 32851591 Free PMC article.
-
miR-199a Links MeCP2 with mTOR Signaling and Its Dysregulation Leads to Rett Syndrome Phenotypes.Cell Rep. 2015 Sep 22;12(11):1887-901. doi: 10.1016/j.celrep.2015.08.028. Epub 2015 Sep 3. Cell Rep. 2015. PMID: 26344767
-
Reduced AKT/mTOR signaling and protein synthesis dysregulation in a Rett syndrome animal model.Hum Mol Genet. 2011 Mar 15;20(6):1182-96. doi: 10.1093/hmg/ddq563. Epub 2011 Jan 6. Hum Mol Genet. 2011. PMID: 21212100
-
Interpreting the rich dialogue between astrocytes and neurons: An overview in Rett syndrome.Brain Res Bull. 2025 Jul;227:111386. doi: 10.1016/j.brainresbull.2025.111386. Epub 2025 May 15. Brain Res Bull. 2025. PMID: 40378493 Review.
-
MeCP2 expression and function during brain development: implications for Rett syndrome's pathogenesis and clinical evolution.Brain Dev. 2005 Nov;27 Suppl 1:S77-S87. doi: 10.1016/j.braindev.2004.10.008. Epub 2005 Sep 22. Brain Dev. 2005. PMID: 16182491 Review.
References
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous